Chris Manchester

Featured in: Favicon

clinicalleader.com Favicon

sikich.com Favicon

hardenexpress.com.au

Articles

11.12.24 -- AI Can't Help Bad ClinOps/Health Equity Data

Nov 12, 2024 | clinicalleader.com | Dan Schell |J.C. Wilson |Chris Manchester

Digging Through the Hype: Can AI/ML Assist Clinical Development? Join us on November 14th at 11:00am EST to learn approaches to leveraging AI and machine learning when handling clinical data, how to approach the use of Generative AI for analyzing clinical trial data, and how to approach human-in-the-loop data mapping with machine learning. Register here.
08.20.24 -- Automation: From Protocol Definition To Final Submission

Aug 20, 2024 | clinicalleader.com | Brian P. Hermann |Chris Manchester |Narayanrao Pavuluri |Donald Thampy

Webinar: Making an Impact on Sustainability Through Vendor Collaboration and Smart Procurement StrategiesWith reports that industries worldwide could save $437 billion per year by 2030 by improving energy efficiency alone, sustainability initiatives continue to be a driving force behind the evolution of business process and technological development.
06.25.24 -- The Future Of Epilepsy Research And Transformative Treatments

Jun 25, 2024 | clinicalleader.com | Mike Davis |Kevin Landells |Christine Guo |Chris Manchester

CLINICAL TRIAL TECHNOLOGYThe Future Of Epilepsy Research And Transformative TreatmentsUCB's Head of Epilepsy and Rare Syndromes discusses the future of epilepsy treatment and clinical trials. Using Tech Enabled Solutions To Boost Productivity And SustainabilityTrials continue to face challenges related to cost, patient tech adoption, and resource management. Uncover how investing in tech solutions can enhance efficiency and reduce companies' carbon footprint.
From Manual To Automated: Navigating Financial Waters In Clinical Trials

Jun 19, 2024 | clinicalleader.com | Chris Manchester

By Chris Manchester, NetSuite Team Managing Consultant Clinical trials are the backbone of medical innovation, yet the financial intricacies involved can pose significant hurdles. As groundbreaking treatments inch closer to reality, managing the financial aspects of clinical trials efficiently becomes crucial. According to recent surveys, a significant portion of organizations in the life sciences sector struggle with outdated financial processes.
Beyond The Spreadsheet: Revolutionizing CRO Financial Management With Better Technology

Jun 19, 2024 | clinicalleader.com | Chris Manchester

By Chris Manchester, NetSuite Team Managing Consultant For contract research organizations (CROs), the use of Excel has long been the standard tool for managing critical operations from project bidding to financial forecasting. However, as biotech and pharmaceutical sectors surge ahead with innovative therapies and expanded clinical pipelines, the limitations of Excel are becoming increasingly apparent.
From Manual to Automated: Financial Management in Clinical Trials

May 24, 2024 | sikich.com | Chris Manchester

Picture this: you’ve poured your heart and soul into developing a groundbreaking medical treatment. The clinical trials are underway, and hopes are high. But amidst the clinical trials excitement, there’s a looming challenge—financial management. In the life sciences industry, where every step forward represents a leap in medical progress, the importance of financial management cannot be overstated.
Revolutionizing CRO Financial Management with Better Technology

May 20, 2024 | sikich.com | Chris Manchester

In research, insufficient data leads to the wrong hypothesis. It’s akin to fitting a square peg into a round hole. Excel is a square peg. It is the legacy platform that most contract research organizations (CROs) use to service their biotech, drug developer, and pharmaceutical clients. However, it was not built to manage the complexities of CRO business. Excel can handle a lot of data, from research results to billing information.
How Better CRO Project Management Tools Can Pay Off

Oct 17, 2023 | clinicalleader.com | Chris Manchester

By Chris Manchester In our contemporary landscape, we inhabit a data-centric world where the significance of data is paramount. For life sciences companies, and Clinical Research Organizations (CROs) in particular, data holds even greater importance; it is not merely the lifeblood and guiding light of their operations, but their very raison d’être. Hence, the precision and accessibility of this data are of paramount importance.